Athenex
Athenex is a biopharmaceutical company that develops novel immune cell therapies for the treatment of cancer and inflammatory diseases.
Business Model:
Revenue: $121.8M
Employees: 501-1,000
Industries / Tags:
Detailed Athenex Information
Geographic Data
Address: 1001 Main Street
City: Buffalo
State: NY
Zip: 14203
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$60M
Raised Total:$312M
Social
Metrics
3,296,172Website Global Rank
4,606Website Monthly Traffic
Twitter Followers
Description
Athenex is a biopharmaceutical company that develops novel immune cell therapies for the treatment of cancer and inflammatory diseases.
Contact Phone:
+17164272950
Contact Email:
Athenex went public on 6/14/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/14/2017
IPO Valuation:
$607M
Ticker Symbol:
ATNX
IPO Price:
$11/share
Amount Raised:
$66M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2015 | Private Equity Round | 1 | $48.1M |
Mandra Capital Mandra Capital |
8/2012 | Venture Round | $5M | 4/2011 | Venture Round | $4.7M | 12/2013 | Venture Round | 1 | $300k |
Mandra Capital Mandra Capital |
3/2014 | Private Equity Round | 1 | $40M |
Mandra Capital Mandra Capital |
12/2019 | Post-IPO Equity | 1 | $60M |
Kingdon Capital Kingdon Capital Kingdon Capital Kingdon Capital |
8/2022 | Post-IPO Equity | $30M | 6/2018 | Equity | $50M | 6/2020 | Debt | $225M |
OakTree Capital Management |
8/2022 | Post-IPO Equity | $30M | 12/2019 | Private Placement | $60.4M | 7/2018 | Post-IPO Equity | 1 | $50M |
Perceptive Advisors Perceptive Advisors Perceptive Advisors Perceptive Advisors |
2/2010 | Venture Round | $4.1M | 5/2019 | Post-IPO Equity | 2 | $100M |
OrbiMed Perceptive Advisors OrbiMed Perceptive Advisors |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 5/2021 | Kuur Therapeutics | |
| 12/2015 | Comprehensive Drug Enterprises Ltd | |
| 9/2014 | QuaDPharma |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
